Santen Pharmaceutical Co (Santen Pharmaceutical Co) Price-to-Tangible-Book : 2.37 (As of Apr. 28, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-04-28), Santen Pharmaceutical Co's share price is $9.39. Santen Pharmaceutical Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $3.96. Hence, Santen Pharmaceutical Co's Price to Tangible Book Ratio of today is 2.37.

The historical rank and industry rank for Santen Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

SNPHY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.83 Med: 3.98 Max: 5.68
Current: 2.65

During the past 13 years, Santen Pharmaceutical Co's highest Price to Tangible Book Ratio was 5.68. The lowest was 1.83. And the median was 3.98.

SNPHY's Price-to-Tangible-Book is ranked worse than
56.31% of 872 companies
in the Drug Manufacturers industry
Industry Median: 2.34 vs SNPHY: 2.65

A closely related ratio is called PB Ratio. As of today, Santen Pharmaceutical Co's share price is $9.39. Santen Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was $5.71. Hence, Santen Pharmaceutical Co's P/B Ratio of today is 1.64.

Santen Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Santen Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Price-to-Tangible-Book Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Get a 7-Day Free Trial

4.14

3.99

3.10

2.29

2.15

Santen Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.08	2.15	2.17	2.33	2.49

Competitive Comparison of Santen Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santen Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Price-to-Tangible-Book falls into.

Santen Pharmaceutical Co Price-to-Tangible-Book Calculation

Santen Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	9.39	/	3.963
	=	2.37

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Santen Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

SNPHF:USA 4536:Japan SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines

From GuruFocus

Matthews Japan Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood • 04-23-2020

Matthews Japan Fund Comments on Santen Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood • 04-23-2020